VTVT - Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today? | Benzinga
Wednesday, vTv Therapeutics Inc (NASDAQ:VTVT) shares are soaring on a robust session volume of 2.7 million, compared to the average volume of 31.92 K as per the data from Benzinga Pro.
The company closed a private placement to healthcare-focused institutional investors, including a life sciences-focused institutional investor, Samsara BioCapital, and the JDRF T1D Fund, of 464,377 shares at $11.81 per share and pre-funded warrants ...